Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Valneva Begins Manufacturing of Inactivated, Adjuvanted COVID-19 Vaccine, Completes Study Recruitment

americanpharmaceuticalreviewFebruary 05, 2021

Tag: Valneva , COVID-19 vaccine , VLA2001

PharmaSources Customer Service